Identify patients most likely to benefit from immunotherapy through comprehensive biomarker analysis and response prediction
Immunotherapy Matching: Eligibility & Response Prediction
Identify patients most likely to benefit from immunotherapy through comprehensive biomarker analysis and response prediction.
The Problem: Immunotherapy eligibility and response prediction requires complex biomarker analysis across multiple dimensions
Immunotherapy eligibility and response prediction requires complex biomarker analysis across multiple dimensions.
Biomarker analysis scattered across multiple tests
Biomarker analysis scattered across multiple tests
Response prediction uncertainty
Response prediction uncertainty
Complex eligibility criteria
Complex eligibility criteria
The Solution: AI-Powered Precision Solution
Comprehensive immunotherapy biomarker analysis and response prediction.
Improved Immunotherapy Selection
Precise immunotherapy eligibility determination with comprehensive biomarker analysis
Response Prediction
Predict immunotherapy response before treatment initiation
Real-World Results
Measurable outcomes from using this capability
Improved Immunotherapy Selection
Precise immunotherapy eligibility determination with comprehensive biomarker analysis
Response Prediction
Predict immunotherapy response before treatment initiation
See It In Action
Interactive demonstration of this capability
Live Demo Coming Soon
Interactive demonstration for Immunotherapy Matching: Eligibility & Response Prediction will be available here.
Explore Other Co-Pilots
Chemo Co‑Pilot: In‑Silico Chemotherapy Guidance
Evidence-backed chemotherapy recommendations with 70-85% confidence. See which drug classes match your patient's tumor biology with transparent S/P/E reasoning. Action-ready dossiers for same-day tumor board discussions.
AgenticEMR™: Intelligent Clinical Data Management
Transform clinical data management with autonomous AI agents that convert unstructured EMR data into actionable clinical insights.
Oracle Intelligence: Multi-Modal AI Validation Platform
Experience the S/P/E framework - where Sequence, Pathway, and Evidence combine for transparent, auditable variant predictions with 70-85% accuracy.
Forge Intelligence: Generative Therapeutic Design Platform
Experience the AI that designs precision therapeutics from first principles - CRISPR guides, protein inhibitors, and HDR templates engineered for maximum efficacy.
Scribe Intelligence: Conversational AI Co-Pilot
Ask questions naturally, get evidence-backed answers. Progressive disclosure means you get exactly the level of detail you need - start simple and drill down when ready.
CRISPR Intelligence: Advanced Therapeutic R&D Platform
The definitive therapeutic design platform. Evo2-powered guide RNA design with AlphaFold 3 structural validation (pLDDT ≥70). 100% pass rate on validation benchmarks. IND package generation and IP monetization workflow included.
Clinical Trials Co‑Pilot: In‑Silico Trial Matching
Which trials target YOUR tumor's vulnerabilities? We match your pathway burden (DDR, MAPK, PI3K) to trial drug mechanisms—not keywords. Action-ready dossiers for same-day enrollment.
Pathway Analysis: Gene-to-Pathway Mapping
Aggregates sequence disruption scores into pathway-level signals. Integrates with S/P/E framework (40% weight) and Synthetic Lethality analysis.
Therapy Fit: Drug Efficacy Ranking
Ranks drugs by efficacy using Sequence/Pathway/Evidence scoring. Provides confidence, evidence tiers, badges, and transparent rationale.
Toxicity Risk Assessment
Identifies pharmacogene variants and pathway overlap risks. Recommends mitigating foods with personalized explanations.